Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Combining PRP with other treatments can improve hair loss outcomes.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Resistance exercise improves body image in breast cancer survivors.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Reporter characteristics affect detection of hair loss from cancer therapy.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Reporter characteristics affect detection of hair loss from cancer therapy.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Botulinum toxins effectively treat excessive sweating and may help with other skin conditions, but more research is needed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.